Literature DB >> 17894502

A new approach to enantiopure inherently chiral calix[4]arenes: determination of their absolute configurations.

Zhen-Xiang Xu1, Chun Zhang, Qi-Yu Zheng, Chuan-Feng Chen, Zhi-Tang Huang.   

Abstract

A new approach to the synthesis of meta-substituted enantiopure inherently chiral calix[4]arenes by introducing L-Boc-proline as dual functions of the chiral auxiliary has been described. Moreover, the absolute configurations of the enantiomers were determined by CD spectra, X-ray crystallographic analysis, and the chemical derivative method.

Entities:  

Year:  2007        PMID: 17894502     DOI: 10.1021/ol701714q

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Inherently chiral calixarenes: synthesis, optical resolution, chiral recognition and asymmetric catalysis.

Authors:  Shao-Yong Li; Yao-Wei Xu; Jun-Min Liu; Cheng-Yong Su
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

2.  Inherently chiral calix[4]arenes via oxazoline directed ortholithiation: synthesis and probe of chiral space.

Authors:  Simon A Herbert; Laura J van Laeren; Dominic C Castell; Gareth E Arnott
Journal:  Beilstein J Org Chem       Date:  2014-11-25       Impact factor: 2.883

3.  Rational synthesis of benzimidazole[3]arenes by CuII-catalyzed post-macrocyclization transformation.

Authors:  Shohei Tashiro; Tsutomu Umeki; Ryou Kubota; Mitsuhiko Shionoya
Journal:  Chem Sci       Date:  2018-09-05       Impact factor: 9.825

4.  Qualitative analysis of the helical electronic energy of inherently chiral calix[4]arenes: an approach to effectively assign their absolute configuration.

Authors:  Shuang Zheng; Ming-Liang Chang; Jing Zhou; Jing-Wei Fu; Qing-Wei Zhang; Shao-Yong Li; Wei Qiao; Jun-Min Liu
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

5.  Attempted synthesis of a meta-metalated calix[4]arene.

Authors:  Christopher D Jurisch; Gareth E Arnott
Journal:  Beilstein J Org Chem       Date:  2019-08-22       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.